Ken Fisher’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,951
Closed -$570K 1053
2025
Q3
$570K Sell
9,951
-278,122
-97% -$16M ﹤0.01% 762
2025
Q2
$17M Sell
288,073
-42,835
-13% -$2.77M 0.01% 340
2025
Q1
$24.2M Sell
330,908
-9,648
-3% -$797K 0.01% 304
2024
Q4
$28.2M Sell
340,556
-28,655
-8% -$2.26M 0.01% 302
2024
Q3
$26.4M Sell
369,211
-5,001
-1% -$353K 0.01% 307
2024
Q2
$25.6M Sell
374,212
-8,003
-2% -$478K 0.01% 303
2024
Q1
$20.5M Sell
382,215
-1,366
-0.4% -$73.4K 0.01% 333
2023
Q4
$20.4M Sell
383,581
-125,363
-25% -$6.11M 0.01% 324
2023
Q3
$25.3M Buy
+508,944
New +$28.5M 0.01% 320

Other funds holding GMED

Ken Fisher's GMED Position: Q4 2025 in Review

Ken Fisher sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 9,951 shares — an estimated $570K sold.

Ken Fisher first reported a position in GMED in Q3 2023 and held it in 9 quarters. The position peaked at $28.2M in Q4 2024. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Ken Fisher reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Ken Fisher sold 9,951 Globus Medical shares in Q4 2025, an estimated $570K.
  • Ken Fisher first reported a position in Globus Medical in Q3 2023 and held it in 9 quarters.
  • Ken Fisher's Globus Medical position peaked at $28.2M in Q4 2024.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.